Treatment of Sleep Apnea in Patients with Cervical Spinal Cord Injury
Launched by JOHN D. DINGELL VA MEDICAL CENTER · Oct 3, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at new ways to treat sleep apnea, a condition that causes people to have trouble breathing while they sleep, specifically in individuals who have suffered a cervical spinal cord injury (which affects the neck area). The study is for adults aged 18 to 89 who have had this type of injury for more than three months and are not using mechanical ventilation (a machine to help them breathe). They are aiming to find out how to help these patients breathe better during sleep and improve their overall health.
To participate in this trial, candidates must be healthy adults within the specified age range, and they should have a spinal cord injury that meets certain criteria. However, individuals who are very young, pregnant, or have serious health conditions affecting their heart, lungs, or kidneys, among others, will not be eligible. If chosen to participate, individuals will engage in assessments and treatments to help manage sleep apnea, and they will be monitored throughout the study to track any changes in their condition. This research is important as it may lead to better treatment options for those living with both spinal cord injuries and sleep apnea.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. healthy adults between the ages of 18 - 89
- • 2. chronic spinal cord injury patients (T6 and above), \> 3 months since injury and not on mechanical ventilation, and have not received mechanical ventilation via tracheostomy in the past.
- Exclusion Criteria:
- • 1. subjects ≤ 17 yrs old
- • 2. Pregnant and lactating females
- • 3. History of head trauma that resulted in neurological symptoms or loss of consciousness
- • 4. advanced heart, lung, metabolic, liver or chronic kidney disease.
- • 5. severe obstructive or restrictive respiratory defect by PFTs or history of tracheostomy
- • 6. extreme obesity defined for this protocol as BMI ≥ 40 kg/m2 (to avoid the effect of morbid obesity on ventilation).
About John D. Dingell Va Medical Center
The John D. Dingell VA Medical Center is a premier healthcare facility dedicated to providing comprehensive medical services to veterans, while also serving as a vital hub for clinical research and innovation. Located in Detroit, Michigan, the center emphasizes a patient-centered approach and is committed to advancing medical knowledge through rigorous clinical trials. By leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals, the Dingell VA Medical Center aims to improve treatment outcomes and enhance the quality of life for veterans, contributing to the broader scientific community and the advancement of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
Patients applied
Trial Officials
M Safwan Badr, M.D.
Principal Investigator
John D. Dingell VA Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials